Cardinal Health (NYSE:CAH) Maintains "Buy" Rating with Positive Outlook

Core Viewpoint - Cardinal Health is a resilient player in the healthcare services and products industry, competing effectively with major firms and showing growth potential [1][2]. Group 1: Stock Performance and Ratings - Cowen & Co. maintains a "Buy" rating for Cardinal Health, raising its price target from $225 to $233, reflecting confidence in the company's future performance [2][5]. - The stock recently closed at $210.93, with a 1.25% increase, outperforming the S&P 500's 0.5% gain [2][5]. Group 2: Financial Expectations - Cardinal Health's shares have risen by 0.02% over the past month, outperforming the Medical sector's decline of 0.63% [3]. - The Zacks Consensus Estimate forecasts revenue to reach $64.33 billion, marking a 16.41% rise from the prior year [4]. - Expected EPS for the upcoming earnings release on February 5, 2026, is $2.33, representing a 20.73% increase from the previous year [3][5]. - The company's market capitalization is approximately $50.12 billion, with a trading volume of 1,076,104 shares on the NYSE [4].